高级血红素降解产物对肝功能及血流动力学的影响
研究在大鼠、肝癌细胞系及离体灌注肝中探讨Z-BOX A和Z-BOX B对肝功能的影响,并在急性及慢加急性肝衰竭和遗传性非结合性高胆红素血症中检测其水平。发现胆汁淤积性肝衰竭时血清Z-BOX A和B升高约20倍,两者呈剂量依赖性细胞毒性并影响谷胱甘肽氧化还原状态。
要点
- 胆汁淤积性肝衰竭患者血清Z-BOX A和B升高约20倍(p<0.001)。
- Z-BOX A血清半衰期短于Z-BOX B(p=0.035),且Z-BOX A在肝细胞富集约100倍并排入胆汁。
- Z-BOX A和B呈剂量依赖性细胞毒性,影响肝细胞完整性,但不影响门脉血流动力学。
核心结论
- Z-BOX A和Z-BOX B可损害肝细胞完整性,可能介导既往归因于高胆红素血症的肝内外细胞毒性效应。
研究设计与样本
- 研究在大鼠、HepG2和HepaRG细胞、人永生化肝细胞及离体灌注肝中探讨功能影响与机制,并用液相色谱-串联质谱法在急性及慢加急性肝衰竭和遗传性非结合性高胆红素血症中检测Z-BOX A和B。
主要发现
- 生理条件下人和啮齿类动物体内Z-BOX A和B含量相似。
- 人胆汁淤积性肝衰竭时血清Z-BOX A和B浓度升高约20倍(p<0.001),大鼠遗传性胆红素葡萄糖醛酸化缺陷时亦升高约20倍(p<0.001)。
- 药代动力学研究显示Z-BOX A血清半衰期短于其区域异构体Z-BOX B(p=0.035)。
- 两种化合物均被肝细胞摄取,Z-BOX A富集约100倍并排入胆汁。
- 尽管报道BOXes在脑血管有血管收缩特性,但未影响门脉血流动力学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Biliverdin and bilirubin were previously considered end products of heme catabolism; now, however, there is evidence for further degradation to diverse bioactive products. Z-BOX A and Z-BOX B arise upon oxidation with unknown implications for hepatocellular function and integrity. We studied the impact of Z-BOX A and B on hepatic functions and explored their alterations in health and cholestatic conditions. METHODS: Functional implications and mechanisms were investigated in rats, hepatocytic HepG2 and HepaRG cells, human immortalized hepatocytes, and isolated perfused livers. Z-BOX A and B were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in acute and acute-on-chronic liver failure and hereditary unconjugated hyperbilirubinemia. RESULTS: Z-BOX A and B are found in similar amounts in humans and rodents under physiological conditions. Serum concentrations increased ∼20-fold during cholestatic liver failure in humans (p<0.001) and in hereditary deficiency of bilirubin glucuronidation in rats (p<0.001). Pharmacokinetic studies revealed shorter serum half-life of Z-BOX A compared to its regio-isomer Z-BOX B (p=0.035). While both compounds were taken up by hepatocytes, Z-BOX A was enriched ∼100-fold and excreted in bile. Despite their reported vasoconstrictive properties in the brain vasculature, BOXes did not affect portal hemodynamics. Both Z-BOX A and B showed dose-dependent cytotoxicity, affected the glutathione redox state, and differentially modulated activity of Rev-erbα and Rev-erbβ. Moreover, BOXes-triggered remodeling of the hepatocellular cytoskeleton. CONCLUSIONS: Our data provide evidence that higher-order heme degradation products, namely Z-BOX A and B, impair hepatocellular integrity and might mediate intra- and extrahepatic cytotoxic effects previously attributed to hyperbilirubinemia. LAY SUMMARY: Degradation of the blood pigment heme yields the bile pigment bilirubin and the oxidation products Z-BOX A and Z-BOX B. Serum concentrations of these bioactive molecules increase in jaundice and can impair liver function and integrity. Amounts of Z-BOX A and Z-BOX B that are observed during liver failure in humans have profound effects on hepatic function when added to cultured liver cells or infused into healthy rats.
引用
- Seidel RA, Claudel T, Schleser FA, et al. Impact of higher-order heme degradation products on hepatic function and hemodynamics. J Hepatol. 2017. PMID: 28412296. doi:10.1016/j.jhep.2017.03.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。